Multi target action of the herbal combination STW 5 in dyspeptic heartburn
A multi-target action is the key to understanding the effect of herbal medicines in a large number of therapeutic fields. To these belongs also heartburn, frequently occurring in dyspeptic patients, and caused by motility disturbances [1]. As a number of randomized controlled clinical trials have sh...
Saved in:
Published in | Planta Medica |
---|---|
Main Authors | , , , , , |
Format | Conference Proceeding |
Language | English |
Published |
21.07.2009
|
Online Access | Get full text |
Cover
Loading…
Summary: | A multi-target action is the key to understanding the effect of herbal medicines in a large number of therapeutic fields. To these belongs also heartburn, frequently occurring in dyspeptic patients, and caused by motility disturbances [1]. As a number of randomized controlled clinical trials have shown, the herbal medicine STW 5 (Iberogast
®
) is active not only in functional dyspepsia [2], but also in its symptom heartburn [3]. A systematic review, conducted with the aim to elucidate the underlying mode of action, has identified the following mechanisms:
1. Protection of the esophageal mucosa against acidic reflux: STW 5 inhibits mucosal inflammation in an experimental model of acid reflux [4].
2. Enhancing of muscular tone of the lower esophageal sphincter, contributing to the inhibition of gastric reflux into the esophagus [5].
3. Relaxation of fundus and corpus: This allows for a better adaptation of the volume to ingested food, thus reducing intragastric pressure [6,7]
4. Prokinetic effect on gastric antrum, improving gastric function. An onset of this effect within 10min after oral intake of STW 5 has been shown [6,7].
5. Inhibition of increased acid secretion, thus potentially reducing the exposure of gastric and esophageal mucosa to acid. [8].
Possible mechanisms of action of STW 5, acting on multiple targets (explanation see text).
References:
[1] Tack, J. et al. (2006) Gastroenterology 130:1466–1479.
[2] Schmulson, M.J. (2008) Nat. Clin. Pract. Gastr. 5:136–137.
[3] Madisch, et al. (2007) Gut 56, SIII:A336.
[4] Khayyal, M.T. et al. (2008) Neurogastroent. Motil. 20, S2:98.
[5] Schemann, M. et al. (2008) Gastroenterol. 46:1039.
[6] Schemann, M. et al. (2006) Phytomedicine 13:90–99.
[7] Pilichiewicz, A.N. et al. (2006) Neurogastroent. Motil. 18:745.
[8] Khayyal, M.T. et al. (2006) Phytomedicine 13:56–66. |
---|---|
ISSN: | 0032-0943 1439-0221 |
DOI: | 10.1055/s-0029-1234869 |